Table 2.
Covariates | Univariable analysis | Multivariable analysis | ||||||
---|---|---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | |||
Lower | Upper | Lower | Upper | |||||
Age | 1.067 | 1.026 | 1.110 | <0.01 | ||||
Weight (kg) | 0.990 | 0.957 | 1.024 | 0.55 | ||||
Sex | ||||||||
Male | Ref | |||||||
Female | 1.250 | 0.657 | 2.377 | 0.50 | ||||
Type | ||||||||
TD | Ref | |||||||
Intermediate | 1.862 | 0.805 | 4.303 | 0.15 | ||||
AR | 3.066 | 1.442 | 6.520 | <0.01 | ||||
LEDD | 1.003 | 1.001 | 1.005 | <0.01 | 1.002 | 1.000 | 1.004 | <0.05 |
UPRDS-III | 1.095 | 1.057 | 1.133 | <0.01 | 1.071 | 1.033 | 1.109 | <0.01 |
K-MMSE | 0.893 | 0.855 | 0.932 | <0.01 | 0.921 | 0.65 | 0.980 | <0.01 |
Fazekas scale | 2.515 | 1.538 | 4.111 | <0.01 | ||||
Zinc (μg/dL) | 0.972 | 0.936 | 1.009 | 0.14 | 0.953 | 0.919 | 0.988 | <0.01 |
Copper (μg/dL) | 0.997 | 0.983 | 1.010 | 0.62 | ||||
Lead (μg/dL) | 0.940 | 0.646 | 1.369 | 0.75 | ||||
Mercury (μg/L) | 0.919 | 0.777 | 1.089 | 0.33 | ||||
Manganese (μg/L) | 0.955 | 0.850 | 1.073 | 0.44 |
HR, Hazed Ratio; CI, Confidence Interval; UPDRS-III, United Parkinson’s Disease Rating Scale Part 3; LEDD, L-dopa equivalent daily dose; K-MMSE, Korean version of the mini mental state examination scale; TD, Tremor-dominant; AR, Akinetic-rigidity.